Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50290

1.

Long-term expanding human airway organoids for disease modeling.

Sachs N, Papaspyropoulos A, Zomer-van Ommen DD, Heo I, Böttinger L, Klay D, Weeber F, Huelsz-Prince G, Iakobachvili N, Amatngalim GD, de Ligt J, van Hoeck A, Proost N, Viveen MC, Lyubimova A, Teeven L, Derakhshan S, Korving J, Begthel H, Dekkers JF, Kumawat K, Ramos E, van Oosterhout MF, Offerhaus GJ, Wiener DJ, Olimpio EP, Dijkstra KK, Smit EF, van der Linden M, Jaksani S, van de Ven M, Jonkers J, Rios AC, Voest EE, van Moorsel CH, van der Ent CK, Cuppen E, van Oudenaarden A, Coenjaerts FE, Meyaard L, Bont LJ, Peters PJ, Tans SJ, van Zon JS, Boj SF, Vries RG, Beekman JM, Clevers H.

EMBO J. 2019 Jan 14. pii: e100300. doi: 10.15252/embj.2018100300. [Epub ahead of print]

PMID:
30643021
2.

Cystic fibrosis-associated Stenotrophomonas maltophilia strain-specific adaptations and responses to pH.

Gallagher T, Phan J, Oliver A, Chase AB, England WE, Wandro S, Hendrickson C, Riedel SF, Whiteson K.

J Bacteriol. 2019 Jan 14. pii: JB.00478-18. doi: 10.1128/JB.00478-18. [Epub ahead of print]

PMID:
30642989
3.

Application of multiple event analysis as an alternative approach to studying pulmonary exacerbations as an outcome measure.

Juarez-Colunga E, Rosenfeld M, Zemanick ET, Wagner B.

J Cyst Fibros. 2019 Jan 11. pii: S1569-1993(18)30943-3. doi: 10.1016/j.jcf.2018.12.005. [Epub ahead of print]

PMID:
30642785
4.

Zinc Nutritional Status in Patients with Cystic Fibrosis.

Escobedo Monge MF, Barrado E, Alonso Vicente C, Redondo Del Río MP, Marugán de Miguelsanz JM.

Nutrients. 2019 Jan 11;11(1). pii: E150. doi: 10.3390/nu11010150.

PMID:
30642010
5.

TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.

Xia E, Zhang Y, Cao H, Li J, Duan R, Hu J.

Genes (Basel). 2019 Jan 11;10(1). pii: E39. doi: 10.3390/genes10010039.

PMID:
30641980
6.

Recent advances in understanding and managing acute pancreatitis.

Mandalia A, Wamsteker EJ, DiMagno MJ.

Version 2. F1000Res. 2018 Jun 28 [revised 2019 Jan 1];7. pii: F1000 Faculty Rev-959. doi: 10.12688/f1000research.14244.2. eCollection 2018. Review.

7.

Lipid- and polymer-based plexes as therapeutic carriers for bioactive molecules.

Shende P, Ture N, Gaud RS, Trotta F.

Int J Pharm. 2019 Jan 11. pii: S0378-5173(19)30023-7. doi: 10.1016/j.ijpharm.2018.12.085. [Epub ahead of print] Review.

PMID:
30641179
8.

Correction: Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis.

Sherrard LJ, Tai AS, Wee BA, Ramsay KA, Kidd TJ, Ben Zakour NL, Whiley DM, Beatson SA, Bell SC.

PLoS One. 2019 Jan 14;14(1):e0210929. doi: 10.1371/journal.pone.0210929. eCollection 2019.

PMID:
30640960
9.

Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation.

Schnapp Z, Hartman C, Livnat G, Shteinberg M, Elenberg Y.

J Pediatr Gastroenterol Nutr. 2018 Oct 29. doi: 10.1097/MPG.0000000000002197. [Epub ahead of print]

PMID:
30640865
10.

Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.

Wu AC, Kiley JP, Noel PJ, Amur S, Burchard EG, Clancy JP, Galanter J, Inada M, Jones TK, Kropski JA, Loyd JE, Nogee LM, Raby BA, Rogers AJ, Schwartz DA, Sin DD, Spira A, Weiss ST, Young LR, Himes BE.

Am J Respir Crit Care Med. 2018 Dec 15;198(12):e116-e136. doi: 10.1164/rccm.201810-1895ST.

PMID:
30640517
11.

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange for Deep Sedation in a Lung Transplant Candidate With Severe Cystic Fibrosis: A Case Report.

You-Ten KE, Zasso FB.

A A Pract. 2019 Jan 10. doi: 10.1213/XAA.0000000000000964. [Epub ahead of print]

PMID:
30640278
12.

Assessment of adherence and asthma medication ratio (AMR) for a once-daily and twice-daily inhaled corticosteroid/long acting beta agonist (ICS/LABA) for asthma.

Stanford RH, Averell C, Parker ED, Blauer-Peterson C, Reinsch TK, Buikema AR.

J Allergy Clin Immunol Pract. 2019 Jan 9. pii: S2213-2198(19)30001-7. doi: 10.1016/j.jaip.2018.12.021. [Epub ahead of print]

PMID:
30639604
13.

Defective CFTR promotes intestinal proliferation via inhibition of the hedgehog pathway during cystic fibrosis.

Liu K, Wang X, Zou C, Zhang J, Chen H, Tsang L, Yu MK, Chung YW, Wang J, Dai Y, Liu Y, Zhang X.

Cancer Lett. 2019 Jan 10. pii: S0304-3835(19)30008-4. doi: 10.1016/j.canlet.2018.12.018. [Epub ahead of print]

PMID:
30639531
14.

Macrophage polarization: reaching across the aisle?

Bosco MC.

J Allergy Clin Immunol. 2019 Jan 8. pii: S0091-6749(19)30005-3. doi: 10.1016/j.jaci.2018.12.995. [Epub ahead of print]

PMID:
30639344
15.

Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.

Yadav R, Yoo DG, Kahlenberg JM, Bridges SL Jr, Oni O, Huang H, Stecenko A, Rada B.

J Cyst Fibros. 2019 Jan 9. pii: S1569-1993(18)30971-8. doi: 10.1016/j.jcf.2018.12.010. [Epub ahead of print]

PMID:
30638826
16.

High airborne level of Aspergillus fumigatus and presence of azole-resistant TR34/L98H isolates in the home of a cystic fibrosis patient harbouring chronic colonisation with azole-resistant H285Y A. fumigatus.

Paluch M, Lejeune S, Hecquet E, Prévotat A, Deschildre A, Fréalle E.

J Cyst Fibros. 2019 Jan 9. pii: S1569-1993(19)30001-3. doi: 10.1016/j.jcf.2019.01.001. [Epub ahead of print]

PMID:
30638825
17.

A EAACI Drug Allergy Interest Group survey on how European allergy specialists deal with β-lactam allergy.

Torres MJ, Celik G, Whitaker P, Atanaskovic-Markovic M, Barbaud A, Bircher A, Blanca M, Brockow K, Caubet JC, Cernadas J, Chiriac A, Demoly P, Garvey LH, Merk H, Mosbech H, Nakonechna A, Romano A.

Allergy. 2019 Jan 14. doi: 10.1111/all.13721. [Epub ahead of print]

PMID:
30637768
18.

Protein stability and degradation in health and disease.

Clausen L, Abildgaard AB, Gersing SK, Stein A, Lindorff-Larsen K, Hartmann-Petersen R.

Adv Protein Chem Struct Biol. 2019;114:61-83. doi: 10.1016/bs.apcsb.2018.09.002. Epub 2018 Nov 28.

PMID:
30635086
19.

Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.

Genschmer KR, Russell DW, Lal C, Szul T, Bratcher PE, Noerager BD, Abdul Roda M, Xu X, Rezonzew G, Viera L, Dobosh BS, Margaroli C, Abdalla TH, King RW, McNicholas CM, Wells JM, Dransfield MT, Tirouvanziam R, Gaggar A, Blalock JE.

Cell. 2019 Jan 10;176(1-2):113-126.e15. doi: 10.1016/j.cell.2018.12.002.

PMID:
30633902
20.

Widespread alterations of the peripheral blood innate immune cell profile in cystic fibrosis reflect lung pathology and may inform patient management.

Mulcahy EM, Cooley MA, McGuire H, Asad S, Fazekas de St Groth B, Beggs SA, Roddam LF.

Immunol Cell Biol. 2019 Jan 11. doi: 10.1111/imcb.12230. [Epub ahead of print]

PMID:
30633378

Supplemental Content

Loading ...
Support Center